semaglutide pharmaceutical company Ozempic maker Novo Nordisk to acquire obesity drug developer in $1B deal Novo Nordisk | Fox Business
Description
Early clinical results suggest the treatment is safe and well tolerated.
How many capsules are included
Explore Hers for virtual weight loss care, GLP-1 options, oral kits, and app-based support with upfront pricing.
Novo Nordisk, Eli Lilly, Pfizer, Amgen and others are all competing to develop stronger and more convenient weight loss drugs
